

Richard Parker
Richard Parker is a partner in the Washington, D.C. office of Milbank. He was previously a partner at Gibson, Dunn & Crutcher and a member of the Firm’s Antitrust and Competition Practice Group. Mr. Parker is a leading antitrust lawyer who has successfully represented clients before both enforcement agencies and the courts. As a trial lawyer and an antitrust regulatory lawyer, Mr. Parker has been involved in many major antitrust representations, including merger clearance cases, cartel matters, class actions, and government civil investigations. He has extensive experience representing clients in matters before the Federal Trade Commission (FTC) and the U.S. Department of Justice Antitrust Division. His experience in high-profile merger matters have earned him high honors, including being recognized by Chambers USA as a leading Lawyer in Antitrust, by Global Competition Review as “Litigator of the Week” and as a finalist for “Lawyer of the Year”, by the Legal Times, Best Lawyers in America, Lawdragon, and by Super Lawyers Magazine as one of the “Top 100 Washington, DC Lawyers”. Mr. Parker also was included on Benchmark Litigation’s “Top 100 Trial Lawyers in America” list. Mr. Parker joins the firm from O’Melveny & Myers where he served as co-chair of the Antitrust and Competition Practice. From 1998 to 2001, he served as the Senior Deputy Director and then as Director of the Bureau of Competition at the FTC.
Distinctions
Auteurs associés
1302 | Évènements

Articles
3835 Bulletin
2990
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On September 4, 2019, the U.S. Department of Justice’s Antitrust Division filed a complaint in the Northern District of Ohio challenging Novelis Inc.’s proposed (...)
223
This article has been nominated for the 2016 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The Federal Trade Commission (“FTC”) has reached a settlement resolving its claims that Cephalon, Inc. violated the antitrust laws by entering into reverse payment (...)
187
This article has been nominated for the 2015 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Issue In a decision that is likely to result in increased federal enforcement actions against companies that suffer data security breaches but are found not to (...)
435
But Decision Raises as Many Questions as it Answers The Supreme Court yesterday held that it may be unlawful under the antitrust laws for a brand-name drug manufacturer to resolve patent litigation against an allegedly infringing generic drug maker by paying the generic to forestall market (...)
554 Revue
554
Dans cette interview, Gary Zanfagna parle de son expérience en tant que Directeur concurrence et Conseiller général associé de Honeywell, et en particulier des problèmes auxquels est confrontée une entreprise opérant au niveau mondial. Interview réalisée par Richard G. Parker, associé O’Melveny & (...)